RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Assessment of thyroid-specific quality of life in patients with benign symptomatic thyroid nodules treated with radiofrequency or ethanol ablation: a prospective multicenter study

      한글로보기

      https://www.riss.kr/link?id=A107959096

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Radiofrequency ablation (RFA) and ethanol ablation (EA) are effective and safe for benign symptomatic thyroid nodules (BSTNs). However, relatively little is known about the effects of these procedures on patients’ quality of life (QoL). This prospective, multicenter study evaluated the effects of RFA and EA on changes in thyroid-specific QoL in patients with BSTNs and assessed the volume reduction and safety of these procedures.
      Methods: Eighty-six consecutive patients with 86 BSTNs were prospectively included from two medical centers. RFA was performed for 55 BSTNs with solidity ≥50% and EA was performed for 31 BSTNs with solidity <50%. QoL was evaluated using an 11-scale, multiple-choice thyroidspecific QoL questionnaire. Nodule characteristics and QoL were evaluated at diagnosis and 1, 6, and 12 months after treatment. Overall QoL was rated from 0 (good) to 4 (poor).
      Results: The mean longest size and volume of the index nodule were 4.2±1.5 cm and 21.6±22.1 mL, respectively. Patients received 1.1 treatments on average (range, 1 to 2). Significant posttreatment volume reductions were noted; however, the EA group showed a higher volume reduction than the RFA group at 1 (78.7%-16.1% vs. 49.1%-15.8%), 6 (86.3%-21.7% vs. 73.0%-14.5%), and 12 (90.9%-14.9% vs. 80.3%-12.4%) months. The score for each scale of the QoL questionnaire improved significantly during follow-up (all P<0.001). Overall QoL improved significantly, from 1.7±0.9 at diagnosis to 0.6±0.7 at the 12-month follow-up (P<0.001). There were no major complications.
      Conclusion: Both RFA and EA are safe and effective in reducing nodule volume and improving thyroid-specific QoL in patients with BSTNs.
      번역하기

      Purpose: Radiofrequency ablation (RFA) and ethanol ablation (EA) are effective and safe for benign symptomatic thyroid nodules (BSTNs). However, relatively little is known about the effects of these procedures on patients’ quality of life (QoL). Thi...

      Purpose: Radiofrequency ablation (RFA) and ethanol ablation (EA) are effective and safe for benign symptomatic thyroid nodules (BSTNs). However, relatively little is known about the effects of these procedures on patients’ quality of life (QoL). This prospective, multicenter study evaluated the effects of RFA and EA on changes in thyroid-specific QoL in patients with BSTNs and assessed the volume reduction and safety of these procedures.
      Methods: Eighty-six consecutive patients with 86 BSTNs were prospectively included from two medical centers. RFA was performed for 55 BSTNs with solidity ≥50% and EA was performed for 31 BSTNs with solidity <50%. QoL was evaluated using an 11-scale, multiple-choice thyroidspecific QoL questionnaire. Nodule characteristics and QoL were evaluated at diagnosis and 1, 6, and 12 months after treatment. Overall QoL was rated from 0 (good) to 4 (poor).
      Results: The mean longest size and volume of the index nodule were 4.2±1.5 cm and 21.6±22.1 mL, respectively. Patients received 1.1 treatments on average (range, 1 to 2). Significant posttreatment volume reductions were noted; however, the EA group showed a higher volume reduction than the RFA group at 1 (78.7%-16.1% vs. 49.1%-15.8%), 6 (86.3%-21.7% vs. 73.0%-14.5%), and 12 (90.9%-14.9% vs. 80.3%-12.4%) months. The score for each scale of the QoL questionnaire improved significantly during follow-up (all P<0.001). Overall QoL improved significantly, from 1.7±0.9 at diagnosis to 0.6±0.7 at the 12-month follow-up (P<0.001). There were no major complications.
      Conclusion: Both RFA and EA are safe and effective in reducing nodule volume and improving thyroid-specific QoL in patients with BSTNs.

      더보기

      다국어 초록 (Multilingual Abstract)

      Purpose: Radiofrequency ablation (RFA) and ethanol ablation (EA) are effective and safe for benign symptomatic thyroid nodules (BSTNs). However, relatively little is known about the effects of these procedures on patients’ quality of life (QoL). This prospective, multicenter study evaluated the effects of RFA and EA on changes in thyroid-specific QoL in patients with BSTNs and assessed the volume reduction and safety of these procedures.Methods: Eighty-six consecutive patients with 86 BSTNs were prospectively included from two medical centers. RFA was performed for 55 BSTNs with solidity ≥50% and EA was performed for 31 BSTNs with solidity <50%. QoL was evaluated using an 11-scale, multiple-choice thyroid-specific QoL questionnaire. Nodule characteristics and QoL were evaluated at diagnosis and 1, 6, and 12 months after treatment. Overall QoL was rated from 0 (good) to 4 (poor).Results: The mean longest size and volume of the index nodule were 4.2±1.5 cm and 21.6±22.1 mL, respectively. Patients received 1.1 treatments on average (range, 1 to 2). Significant post-treatment volume reductions were noted; however, the EA group showed a higher volume reduction than the RFA group at 1 (78.7%-16.1% vs. 49.1%-15.8%), 6 (86.3%-21.7% vs. 73.0%-14.5%), and 12 (90.9%-14.9% vs. 80.3%-12.4%) months. The score for each scale of the QoL questionnaire improved significantly during follow-up (all P<0.001). Overall QoL improved significantly, 1.7±0.9 at diagnosis to 0.6±0.7 at the 12-month follow-up (P<0.001). There were no major complications.Conclusion: Both RFA and EA are safe and effective in reducing nodule volume and improving thyroid-specific QoL in patients with BSTNs.
      번역하기

      Purpose: Radiofrequency ablation (RFA) and ethanol ablation (EA) are effective and safe for benign symptomatic thyroid nodules (BSTNs). However, relatively little is known about the effects of these procedures on patients’ quality of life (QoL). Thi...

      Purpose: Radiofrequency ablation (RFA) and ethanol ablation (EA) are effective and safe for benign symptomatic thyroid nodules (BSTNs). However, relatively little is known about the effects of these procedures on patients’ quality of life (QoL). This prospective, multicenter study evaluated the effects of RFA and EA on changes in thyroid-specific QoL in patients with BSTNs and assessed the volume reduction and safety of these procedures.Methods: Eighty-six consecutive patients with 86 BSTNs were prospectively included from two medical centers. RFA was performed for 55 BSTNs with solidity ≥50% and EA was performed for 31 BSTNs with solidity <50%. QoL was evaluated using an 11-scale, multiple-choice thyroid-specific QoL questionnaire. Nodule characteristics and QoL were evaluated at diagnosis and 1, 6, and 12 months after treatment. Overall QoL was rated from 0 (good) to 4 (poor).Results: The mean longest size and volume of the index nodule were 4.2±1.5 cm and 21.6±22.1 mL, respectively. Patients received 1.1 treatments on average (range, 1 to 2). Significant post-treatment volume reductions were noted; however, the EA group showed a higher volume reduction than the RFA group at 1 (78.7%-16.1% vs. 49.1%-15.8%), 6 (86.3%-21.7% vs. 73.0%-14.5%), and 12 (90.9%-14.9% vs. 80.3%-12.4%) months. The score for each scale of the QoL questionnaire improved significantly during follow-up (all P<0.001). Overall QoL improved significantly, 1.7±0.9 at diagnosis to 0.6±0.7 at the 12-month follow-up (P<0.001). There were no major complications.Conclusion: Both RFA and EA are safe and effective in reducing nodule volume and improving thyroid-specific QoL in patients with BSTNs.

      더보기

      참고문헌 (Reference)

      1 Zhang M, "Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma : results of over 5 years'follow-up" 30 : 408-417, 2020

      2 백정환 ; 하은주 ; 최영준 ; 성진용 ; 김재균 ; 송영기, "Radiofrequency versus Ethanol Ablation for Treating Predominantly Cystic Thyroid Nodules: A Randomized Clinical Trial" 대한영상의학회 16 (16): 1332-1340, 2015

      3 안혜신 ; 김수진 ; 박성희 ; 서미리내, "Radiofrequency ablation of benign thyroid nodules: evaluation of the treatment efficacy using ultrasonography" 대한초음파의학회 35 (35): 244-252, 2016

      4 Yoo RE, "Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: a case report and literature review" 97 : e0003-, 2018

      5 Chen F, "Radiofrequency ablation for treatment of benign thyroid nodules: a PRISMA-compliant systematic review and meta-analysis of outcomes" 95 : e4659-, 2016

      6 Garberoglio R, "Radiofrequency ablation for thyroid nodules : which indications?" 18 : 423-430, 2015

      7 Schmitz-Winnenthal FH, "Quality of life is not influenced by the extent of surgery in patients with benign goiter" 396 : 1157-1163, 2011

      8 Barbus E, "Quality of life in thyroid cancer patients : a literature review" 90 : 147-153, 2017

      9 Oddo S, "Quality of life in patients treated with radiofrequency ablation for thyroid nodules" 4 : 1-, 2016

      10 Yue WW, "Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules : a retrospective cohort study" 6 : 37838-, 2016

      1 Zhang M, "Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma : results of over 5 years'follow-up" 30 : 408-417, 2020

      2 백정환 ; 하은주 ; 최영준 ; 성진용 ; 김재균 ; 송영기, "Radiofrequency versus Ethanol Ablation for Treating Predominantly Cystic Thyroid Nodules: A Randomized Clinical Trial" 대한영상의학회 16 (16): 1332-1340, 2015

      3 안혜신 ; 김수진 ; 박성희 ; 서미리내, "Radiofrequency ablation of benign thyroid nodules: evaluation of the treatment efficacy using ultrasonography" 대한초음파의학회 35 (35): 244-252, 2016

      4 Yoo RE, "Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: a case report and literature review" 97 : e0003-, 2018

      5 Chen F, "Radiofrequency ablation for treatment of benign thyroid nodules: a PRISMA-compliant systematic review and meta-analysis of outcomes" 95 : e4659-, 2016

      6 Garberoglio R, "Radiofrequency ablation for thyroid nodules : which indications?" 18 : 423-430, 2015

      7 Schmitz-Winnenthal FH, "Quality of life is not influenced by the extent of surgery in patients with benign goiter" 396 : 1157-1163, 2011

      8 Barbus E, "Quality of life in thyroid cancer patients : a literature review" 90 : 147-153, 2017

      9 Oddo S, "Quality of life in patients treated with radiofrequency ablation for thyroid nodules" 4 : 1-, 2016

      10 Yue WW, "Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules : a retrospective cohort study" 6 : 37838-, 2016

      11 Promberger R, "Quality of life after thyroid surgery in women with benign euthyroid goiter : influencing factors including Hashimoto's thyroiditis" 207 : 974-979, 2014

      12 Silvia Oddo ; Edineia Felix ; Michele Mussap ; Massimo Giusti, "Quality of Life in Patients Treated with Percutaneous Laser Ablation for Non-Functioning Benign Thyroid Nodules: A Prospective Single-Center Study" 대한영상의학회 19 (19): 175-184, 2018

      13 Papini E, "Minimally-invasive treatments for benign thyroid nodules : a Delphi-based consensus statement from the Italian minimallyinvasive treatments of the thyroid(MITT)group" 36 : 376-382, 2019

      14 조세진 ; 백정환 ; 정새롬 ; 최영준 ; 이정현, "Long-Term Results of Thermal Ablation of Benign Thyroid Nodules: A Systematic Review And Meta-Analysis" 대한내분비학회 35 (35): 339-350, 2020

      15 Valcavi R, "Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients" 21 : 887-896, 2015

      16 백정환 ; 임영희 ; 박혜선 ; 최영준 ; 송영기 ; 이정현, "Ethanol ablation as a treatment strategy for benign cystic thyroid nodules: a comparison of the ethanol retention and aspiration techniques" 대한초음파의학회 38 (38): 166-171, 2019

      17 한수연 ; 신정희 ; 나동규 ; 하은주 ; 안혜신 ; 임현경 ; 이정현 ; 박정선 ; 김지훈 ; 성진용 ; Joon Hyung Lee ; 백정환 ; 윤정현 ; Jung Suk Sim ; Kwang Hwi Lee ; 백선미 ; 정소령 ; Yeo Koon Kim ; 최윤정, "Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology" 대한영상의학회 20 (20): 609-620, 2019

      18 Chung SR, "Efficacy of radiofrequency ablation for recurrent thyroid cancer invading the airways" 31 : 2153-2160, 2021

      19 정소령 ; 백정환 ; 이정현 ; Young Kee Shong ; 성진용 ; 김규선 ; Ducky Lee ; 김지훈 ; 백선미 ; 심정석 ; 나동규, "Efficacy and Safety of Radiofrequency Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study" 대한영상의학회 19 (19): 167-174, 2018

      20 이민경 ; 백정환 ; 정새롬 ; 최영준 ; 이유미 ; 김태용 ; 이정현, "Effectiveness of Injecting Cold 5% Dextrose into Patients with Nerve Damage Symptoms during Thyroid Radiofrequency Ablation" 대한내분비학회 35 (35): 407-415, 2020

      21 손혜민 ; 김지훈 ; 김수진 ; 유노을 ; 배정모 ; 서효빈 ; 나동규, "Distribution and malignancy risk of six categories of the pathology reporting system for thyroid core-needle biopsy in 1,216 consecutive thyroid nodules" 대한초음파의학회 39 (39): 159-165, 2020

      22 Morris-Wiseman LF, "Decreased quality of life in patients with postoperative hypoparathyroidism after thyroid cancer surgery" 32 : 534-536, 2020

      23 Bergenfelz A, "Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients" 393 : 667-673, 2008

      24 Lee Min Kyoung ; 백정환 ; Suh Chong Hyun ; 정새롬 ; 최영준 ; 이정현 ; 하은주 ; Na Dong Gyu, "Clinical practice guidelines for radiofrequency ablation of benign thyroid nodules: a systematic review" 대한초음파의학회 40 (40): 256-264, 2021

      25 Gharib H, "American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations" 16 : 468-475, 2010

      26 Chung MS, "A scoring system for prediction of cervical lymph node metastasis in patients with head and neck squamous cell carcinoma" 40 : 1049-1054, 2019

      27 Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer" 26 : 1-133, 2016

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2014-01-06 학술지명변경 한글명 : 대한초음파의학회지 -> ULTRASONOGRAPHY
      외국어명 : 미등록 -> ULTRASONOGRAPHY
      KCI등재
      2011-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-04-10 학회명변경 영문명 : Korean Society Of Medical Ultrasound -> Korean Society of Ultrasound in Medicine KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.33 0.33 0.23
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.17 0.13 0.599 0.18
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼